Symposium: Sex, gender, and the brain: New perspectives on psychiatric and neurological disorders

Date:2 October 2025
Time:15:00 – 18:00 (CEST)
Location:Netherlands Institute for Neuroscience (NIN), Meibergdreef 47, 1105 BA, Amsterdam

Share this

Join neuroscience researchers on October 2nd as they explain how sex differences and hormones shape psychiatric and neurological disorders, from optimizing psychosis care in women to unravelling patterns in frontotemporal dementia or depression. 

Program

15:00 – 15:10 Walk-in
15:10 – 15:15 Word of Welcome by TN2 organization
15:15 – 15:50 Keynote lecture by Prof. Iris Sommer – From early detection to hormonal care: Optimizing treatment for women with psychosis
15:50 – 16:10 Presentation by Dr. Sterre de Boer – Sex differences in frontotemporal dementia: Unraveling genetic and sporadic patterns
16:10 – 16:30 Presentation by Dr. Margot Morssinkhof – Sex, gender and hormones: Depression risk across the lifespan
16:30 – 16:55 Panel discussion with all speakers
16:55 – 17:05 Wrap up
17:05 – 18:00 Network and drinks

Speakers

Iris Sommer

University Medical Center Groningen (UMCG)

Short Abstract

Iris Sommer is a psychiatrist and Professor at the Department of Neuroscience University Medical Center Groningen. Her areas of focus are psychosis, schizophrenia, treatment of women in psychiatry. Women with a schizophrenia-spectrum disorder (SSD) have a better clinical profile than do men at the start of their illness but progress to the same state within the first few years of living with SSD. There are benefits to be gained across different areas in the care currently offered to women with psychosis. An important point for improvement is the early detection of female-specific signs of a first episode of psychosis, to shorten the duration of untreated psychosis, with prompt access to early intervention services. Special attention should be paid to sexual health, and to any history of childhood trauma. Antipsychotics require dosing and prescription tailored to the female physiology that considers hormonal life phases such as menopause. Switching to prolactin-sparing medications can benefit both mental and somatic health. Finally, hormone replacement therapy should be considered for postmenopausal women. By providing female-specific care, women with schizophrenia-spectrum disorders will have optimal chances to fare well. 

Sterre de Boer

Amsterdam UMC

Short Abstract

Sterre de Boer is a medical doctor and postdoctoral researcher at the Alzheimer Center Amsterdam, Amsterdam UMC, where she also obtained her PhD in 2024. During her clinical rotation in the psychiatric department, Sterre became intrigued by the symptomatic and diagnostic complexity of frontotemperal dementia (FTD). She will discuss two of her publications on gender differences in frontotemporal dementia, which were published in 2021 and 2025.  

Margot Morssinkhof

Amsterdam UMC

Short Abstract

Margot Morssinkhof is a postdoctoral researcher at the Department of Medical Psychology at the Amsterdam UMC. Previously, as a PhD student, she was embedded in the Department of Psychiatry at the OLVG and the Departments of Psychiatry and Endocrinology of the Amsterdam UMC. Her research focuses on the associations between sex hormones and well-being, with a focus on clinical contexts and medication, including gender-affirming hormones, hormonal contraceptives and the menstrual cycle. Her broader research interest is in the role of sex hormone changes in mental well-being, and in sex- and gender sensitive research in neuroscience and psychiatry. She will present on the role of gender and sex hormones (menstruation, menopause, hormonal contraceptives) on depression.  

Contact

Questions regarding this TN2 symposium? Contact the Amsterdam Neuroscience team.